DEVELOPING NEW DRUGS FOR OVARIAN-CANCER - A CHALLENGING TASK IN A CHANGING REALITY

被引：11
作者：
CANETTA, RM
CARTER, SK
机构：
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1984年 / 107卷 / 02期
关键词：
D O I：
10.1007/BF00399382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 124
页数：14
相关论文
共 165 条
[1]  
AABO K, 1982, CANCER TREAT REP, V66, P407
[2]  
ALBERTS DS, 1980, LANCET, V2, P340
[3]  
ALTMAN SJ, 1978, CANCER TREAT REP, V62, P389
[4]  
AMES MM, 1982, CANCER TREAT REP, V66, P1579
[5]  
Arseneau J C, 1983, Invest New Drugs, V1, P185
[6]  
BAKER LH, 1976, CANCER TREAT REP, V60, P1389
[7]  
BAKER LH, 1974, P AM ASSOC CANC RES, V15, P182
[8]   USE OF HIGH-DOSE CIS-DICHLORODIAMMINE PLATINUM-(II) (NSC-119875) FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE OVARY [J].
BARKER, GH ;
WILTSHAW, E .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (12) :1192-1199
[9]  
BARLOW JJ, 1976, CANCER TREAT REP, V60, P527
[10]  
BARLOW JJ, 1982, P ASCO, V1, P119
12345678910